Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 29R9YG | — |
expiration date was passed that the date patient was given the injection; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 87-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 29R9YG, expiry date 24-JUL-2023) for prophylaxis. On 07-MAR-2024, the patient received Arexvy. On 07-MAR-2024, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: expiration date was passed that the date patient was given the injection). The outcome of the expired vaccine used was not applicable.